Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
Conditions: Hypercholesterolemia; Chronic Kidney Disease Requiring Chronic Dialysis Interventions: Drug: Evolocumab + ezetimibe; Drug: Placebo + ezetimibe Sponsors: Policlinico Casilino ASL RMB; IRCCS San Raffaele Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cholesterol | Dialysis | Research | Statin Therapy | Urology & Nephrology | Vytorin | Zetia